Sangamo Therapeutics
SGMO
SGMO
158 hedge funds and large institutions have $742M invested in Sangamo Therapeutics in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 47 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 157 → 158 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
158
Holding in Top 10
1
Calls
$196M
Puts
$8.47M
Top Buyers
| 1 | +$18.3M | |
| 2 | +$8.53M | |
| 3 | +$8.3M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$6.01M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$4.56M |
Top Sellers
| 1 | -$30.8M | |
| 2 | -$7.35M | |
| 3 | -$4.82M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$4.42M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.8M |